Tune into our Podcast category for the latest seasons and episodes of the “Cut the Chat Life Science Insider” podcast by Seuss+.
Here, we announce new episodes and share synopses that dive deep into the heart of life science discussions, featuring insights from industry experts and insiders.
Get ready for thought-provoking content designed to enlighten and inspire professionals within the life sciences sector.
Tune in to Cut The Chat’s Season 2, Episode 1 as Seuss+ CEO Sabine Hutchison explores with Stephanie Oestreich of MIF the intersections of investment, scientific breakthroughs, and the quest for a Myeloma cure. Dive into a conversation about the challenges and triumphs of specialty funds and the impact of strategic investments on clinical trials.
Episode Five of Cut the Chat – Life Science Insider. Vivian van de Walle unfolds as a captivating exploration of the pivotal role effective collaboration plays in the intersection of science and business within the biotech landscape.
Episode Four of Cut the Chat – Life Science Insider. Our guest speaker, Ben Osborn, Eastern Cluster President at IDM, Biopharma, Pfizer will share his extensive knowledge and insights on the crucial topic of DEI.
Today we embark on an insightful journey to explore the strategies employed by Allison and learn from experiences. There are many challenges which biotech’s deal with, our quest today leads us to tackle four hurdles that biotech companies encounter in their pursuit of innovation and life-changing breakthroughs.
Biotech Science and Creativity: We sit down with Dr. Jennifer Buell, President and CEO of Mint Therapeutics and Chairman of the Executive Council at Agenus Bio
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
We can help you